Driscoll Martin J 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Aug 3, 2017
Insider Transaction Report
Form 4
Driscoll Martin J
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2017-08-03$12.43/sh+1,000$12,430→ 54,400 total - Purchase
Common Stock
2017-08-03$12.28/sh+1,000$12,280→ 53,400 total